Neil Bodick

All filings by Neil Bodick on record concern Flexion Therapeutics Inc. Between 18 February 2014 and 3 January 2020, the trades on record add up to 44 filings.

In open-market terms, that means 7 purchases worth €100k on one side and 23 sales worth €2.6M on the other. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants and 8 option exercises. 2020 to date brings no purchases and 1 sale.

In size, the median ticket on the buying side is €8,042. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 7 January 2020 came the latest disclosure, an open-market sale in Flexion Therapeutics Inc. The last insider purchase was made public on 22 November 2017, 3,274 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.